Home » Drug Information » Recently Approved Drugs » 1997
Medical Areas: Nephrology/Urology
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Boehringer Ingelheim
Approval Status: Approved October 1997
Treatment Area: benign prostatic hypertrophy (BPH)
FLOMAX has been approved for the treatment of benign prostatic
hypertrophy (BPH). Boehringer Ingelheim, which licensed the product
from originator Yamanouchi, will market the product in the U.S.
